Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Pain, Intractable × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Gastrointestinal Stromal Tumors 9 Bone Neoplasms 7 Sarcoma 5 Neoplasms 3 Sarcoma, Kaposi 2 Rhabdomyosarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pain 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Carcinoma, Renal Cell 2 Anemia 2 Acquired Immunodeficiency Syndrome 2 Waldenstrom Macroglobulinemia 1 Venous Thromboembolism 1 Stomach Neoplasms 1 Sarcoma, Ewing 1 Rhabdomyosarcoma, Alveolar 1 Recurrence 1 Rectal Neoplasms 1 Psoriasis 1 Progressive Gastrointestinal Stromal Tumor 1 Piebaldism 1 Pancreatic Neoplasms 1 Pain, Intractable 1 Osteosarcoma 1 Osteoporosis 1 Neurotoxicity Syndromes 1 Neoplasms, Plasma Cell 1 Myelodysplastic Syndromes 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00381095 2021-01-20

COPE

Pfizer

Phase 4 Terminated

152 enrolled 14 charts

Bone Neoplasms, Neoplasms, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡